Pacific Pharma Group, LLC, is a “niche” consulting company prepared to help you with taking your pharmaceutical or nutraceutical to market.

Jon Ruckle, MD, CPI

Jon L. Ruckle MD, the Principal and founder of Pacific Pharma Group, LLC, brings 20 years of Investigator experience with over 350 clinical trials, most of which were Phase I or other early development studies.

His CV and List of Studies are available for your review. Pacific Pharma Group is not a full service CRO. In collaboration with selected consultants and industry providers, Dr. Ruckle primarily offers “niche” services focusing on protocol design, compound development strategy, and medical monitoring.



and Royce Morrison, MD, MSEE, CPI

Royce provides consultative support to Pharma and Biotech product development teams, CROs, program managers, project managers and research site teams – regarding protocol design, clinical research safety, safety data analysis, risk mitigation, Medical Monitoring, Data Monitoring, and investigator mentoring.  His CV and study list is available for your review.

At Stanford University, Dr. Morrison earned BS and MS degrees in electrical engineering, then completed medical school. As a board-certified Internal Medicine specialist in Seattle, he provided office- and hospital-based consultative and primary care in private practice. Transitioned to Group Health Cooperative, his practice emphasized geriatric and HIV/AIDS care, and he shared responsibility for evidence review, guidelines development, formulary decisions and contractual coverage determinations.

Dr. Morrison joined a state-of-the-art early-phase clinical pharmacology research site, serving as Principal Investigator, Medical Director, Director of Clinical Strategy, and Chief Medical Officer through 11 years, experiencing rapid growth and developing complex study capabilities in cardiac safety, radiolabeled drug and first-in-human studies. The site team supported drug, biologic and vaccine product development programs for large and small pharmaceutical and biotechnology companies.

Over more than a year as Executive Vice-Chair of a central IRB, Dr. Morrison developed broad expertise regarding regulatory obligations and oversight issues of study sponsors, research sites and investigators.

Dr. Morrison participates in clinical research professional organizations including DIA, Association of Clinical Pharmacology Units, American College of Clinical Pharmacology, Academy of Physicians in Clinical Research, Pharmaceutical and Bioscience Society International. He has frequently chaired and presented in their educational Sessions and Forums. In the US Northwest, he is Past President of the Northwest Association for Biomedical Research and serves as expert reviewer of grant funding applications to the Washington Life Sciences Discovery Fund.